Hyperthermotherapy for postoperative local recurrences of rectal cancer.

Masahiro Kuroda, A. Hizuta, H. Iwagaki, E. Makihata, Jun-Ichi Asaumi, K. Nishikawa, X. S. Gao, T. Nakagawa, I. Togami, Yoshihiro Takeda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Between November 1984 and August 1992 we used hyperthermotherapy in six cases of local recurrence of rectal cancer. Hyperthermotherapy was performed on the average 8.7 times (range: 3-18) for each patient for 60 min each. All patients underwent combined radiotherapy and received a mean radiation dose of 42.5 Gy (range: 9-60 Gy). Five patients underwent heating within 1 h after irradiation and one patient simultaneously with the irradiation. Four patients underwent combined chemotherapy and two patients immunotherapy. Before the treatment all patients had painful lesions, but pain decreased posttherapeutically in five patients. Performance status improved in two patients. High carcinoembryonic antigen levels prior to the therapy in four patients decreased in all cases after treatment. Posttherapeutical computed tomograms revealed only minor response or no changes. After the treatment, four patients died of exacerbations of recurrent tumors and one patient of distant metastases. The patient who underwent simultaneous radiohyperthermotherapy is presently alive, in August 1992, 38 months after initiation of the treatment. The 50% survival time after initiation of the treatment was 25 months (range: 10-38 months). Hyperthermotherapy combined with radiotherapy, chemotherapy and/or immunotherapy was useful for the alleviation of pain in patients who developed local recurrence after surgery, and improved survival after recurrences can be expected.

Original languageEnglish
Pages (from-to)249-254
Number of pages6
JournalActa Medica Okayama
Volume47
Issue number4
Publication statusPublished - Aug 1993

Fingerprint

Chemotherapy
Radiotherapy
Rectal Neoplasms
Irradiation
Recurrence
Carcinoembryonic Antigen
Surgery
Dosimetry
Tumors
Heating
Immunotherapy
Therapeutics
Drug Therapy
Pain
Survival

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Hyperthermotherapy for postoperative local recurrences of rectal cancer. / Kuroda, Masahiro; Hizuta, A.; Iwagaki, H.; Makihata, E.; Asaumi, Jun-Ichi; Nishikawa, K.; Gao, X. S.; Nakagawa, T.; Togami, I.; Takeda, Yoshihiro.

In: Acta Medica Okayama, Vol. 47, No. 4, 08.1993, p. 249-254.

Research output: Contribution to journalArticle

Kuroda, M, Hizuta, A, Iwagaki, H, Makihata, E, Asaumi, J-I, Nishikawa, K, Gao, XS, Nakagawa, T, Togami, I & Takeda, Y 1993, 'Hyperthermotherapy for postoperative local recurrences of rectal cancer.', Acta Medica Okayama, vol. 47, no. 4, pp. 249-254.
Kuroda M, Hizuta A, Iwagaki H, Makihata E, Asaumi J-I, Nishikawa K et al. Hyperthermotherapy for postoperative local recurrences of rectal cancer. Acta Medica Okayama. 1993 Aug;47(4):249-254.
Kuroda, Masahiro ; Hizuta, A. ; Iwagaki, H. ; Makihata, E. ; Asaumi, Jun-Ichi ; Nishikawa, K. ; Gao, X. S. ; Nakagawa, T. ; Togami, I. ; Takeda, Yoshihiro. / Hyperthermotherapy for postoperative local recurrences of rectal cancer. In: Acta Medica Okayama. 1993 ; Vol. 47, No. 4. pp. 249-254.
@article{064529398be2496dacff210fabc6afe3,
title = "Hyperthermotherapy for postoperative local recurrences of rectal cancer.",
abstract = "Between November 1984 and August 1992 we used hyperthermotherapy in six cases of local recurrence of rectal cancer. Hyperthermotherapy was performed on the average 8.7 times (range: 3-18) for each patient for 60 min each. All patients underwent combined radiotherapy and received a mean radiation dose of 42.5 Gy (range: 9-60 Gy). Five patients underwent heating within 1 h after irradiation and one patient simultaneously with the irradiation. Four patients underwent combined chemotherapy and two patients immunotherapy. Before the treatment all patients had painful lesions, but pain decreased posttherapeutically in five patients. Performance status improved in two patients. High carcinoembryonic antigen levels prior to the therapy in four patients decreased in all cases after treatment. Posttherapeutical computed tomograms revealed only minor response or no changes. After the treatment, four patients died of exacerbations of recurrent tumors and one patient of distant metastases. The patient who underwent simultaneous radiohyperthermotherapy is presently alive, in August 1992, 38 months after initiation of the treatment. The 50{\%} survival time after initiation of the treatment was 25 months (range: 10-38 months). Hyperthermotherapy combined with radiotherapy, chemotherapy and/or immunotherapy was useful for the alleviation of pain in patients who developed local recurrence after surgery, and improved survival after recurrences can be expected.",
author = "Masahiro Kuroda and A. Hizuta and H. Iwagaki and E. Makihata and Jun-Ichi Asaumi and K. Nishikawa and Gao, {X. S.} and T. Nakagawa and I. Togami and Yoshihiro Takeda",
year = "1993",
month = "8",
language = "English",
volume = "47",
pages = "249--254",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "4",

}

TY - JOUR

T1 - Hyperthermotherapy for postoperative local recurrences of rectal cancer.

AU - Kuroda, Masahiro

AU - Hizuta, A.

AU - Iwagaki, H.

AU - Makihata, E.

AU - Asaumi, Jun-Ichi

AU - Nishikawa, K.

AU - Gao, X. S.

AU - Nakagawa, T.

AU - Togami, I.

AU - Takeda, Yoshihiro

PY - 1993/8

Y1 - 1993/8

N2 - Between November 1984 and August 1992 we used hyperthermotherapy in six cases of local recurrence of rectal cancer. Hyperthermotherapy was performed on the average 8.7 times (range: 3-18) for each patient for 60 min each. All patients underwent combined radiotherapy and received a mean radiation dose of 42.5 Gy (range: 9-60 Gy). Five patients underwent heating within 1 h after irradiation and one patient simultaneously with the irradiation. Four patients underwent combined chemotherapy and two patients immunotherapy. Before the treatment all patients had painful lesions, but pain decreased posttherapeutically in five patients. Performance status improved in two patients. High carcinoembryonic antigen levels prior to the therapy in four patients decreased in all cases after treatment. Posttherapeutical computed tomograms revealed only minor response or no changes. After the treatment, four patients died of exacerbations of recurrent tumors and one patient of distant metastases. The patient who underwent simultaneous radiohyperthermotherapy is presently alive, in August 1992, 38 months after initiation of the treatment. The 50% survival time after initiation of the treatment was 25 months (range: 10-38 months). Hyperthermotherapy combined with radiotherapy, chemotherapy and/or immunotherapy was useful for the alleviation of pain in patients who developed local recurrence after surgery, and improved survival after recurrences can be expected.

AB - Between November 1984 and August 1992 we used hyperthermotherapy in six cases of local recurrence of rectal cancer. Hyperthermotherapy was performed on the average 8.7 times (range: 3-18) for each patient for 60 min each. All patients underwent combined radiotherapy and received a mean radiation dose of 42.5 Gy (range: 9-60 Gy). Five patients underwent heating within 1 h after irradiation and one patient simultaneously with the irradiation. Four patients underwent combined chemotherapy and two patients immunotherapy. Before the treatment all patients had painful lesions, but pain decreased posttherapeutically in five patients. Performance status improved in two patients. High carcinoembryonic antigen levels prior to the therapy in four patients decreased in all cases after treatment. Posttherapeutical computed tomograms revealed only minor response or no changes. After the treatment, four patients died of exacerbations of recurrent tumors and one patient of distant metastases. The patient who underwent simultaneous radiohyperthermotherapy is presently alive, in August 1992, 38 months after initiation of the treatment. The 50% survival time after initiation of the treatment was 25 months (range: 10-38 months). Hyperthermotherapy combined with radiotherapy, chemotherapy and/or immunotherapy was useful for the alleviation of pain in patients who developed local recurrence after surgery, and improved survival after recurrences can be expected.

UR - http://www.scopus.com/inward/record.url?scp=0027648499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027648499&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 249

EP - 254

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 4

ER -